Advertisement
Screener

PHARMACYTE BIOTECH, INC. (PMCB) Interest Payable, Current

2.8 / 5 stars · 68/120 Roast Me

PHARMACYTE BIOTECH, INC. Interest Payable, Current

PHARMACYTE BIOTECH, INC. (PMCB) had Interest Payable, Current of $779 as of 2021-04-28, per its 10-K filed 2022-07-28.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current

us-gaap:InterestPayableCurrent · last filed 2022-07-28

  • 2021-04-28: Interest Payable, Current $779.00.
  • 2015-04-30: Interest Payable, Current $0.00.
  • 2014-07-31: Interest Payable, Current $36.61K.
  • 2014-04-30: Interest Payable, Current $33.96K; Interest Payable, Current as first filed $34.83K.
Period endInterest Payable, CurrentInterest Payable, Current as first filed
2021-04-28$779.00
10-K · filed 2022-07-28
2015-04-30$0.00
10-K/A · filed 2016-01-19
2014-07-31$36.61K
10-Q · filed 2014-09-15
2014-04-30$33.96K
10-K/A · filed 2016-01-19
$34.83K
10-K · filed 2014-08-04
2014-01-31$34.83K
10-Q · filed 2014-03-17
2013-10-31$31.80K
10-Q · filed 2013-12-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70